Via Kristy Dorsey
In the four months to the end of October, following the market disruption caused by the coronavirus pandemic outbreak earlier this year, healthcare software provider Craneware has returned to strong revenue growth.
The company said revenue in the first four months of the fiscal year was “significantly ahead” of the same time in 2019 in a statement released ahead of the company’s annual shareholder meeting.
“Results are ahead of management’s expectations for this stage of the year and we expect revenue and adjusted EBITDA for the period ending December 31, 2020 to be ahead of the corresponding period last year, setting the stage for a return to double-digit growth in the future,” management added.
Scottish healthcare tech provider happy with ‘solid sales traction’ in the United States
Craneware, headquartered in Edinburgh, sells healthcare providers located mainly in the United States with billing and financial management tools. At its offices in Atlanta, Pittsburgh and the Scottish capital, the company hires 350 individuals.
Craneware announced a 5 percent growth in sales and profit for the fiscal year ended June. That’s despite the difficulties created in the last quarter of the fiscal year by the Covid 19 pandemic.
The firm said that with U.S. hospital leadership teams, its Trisus platform “continues to resonate” Trisus offers the opportunity to compile, check and correct data so that financial and organizational efficiency can be enhanced by hospitals.
After the U.S. corporation sells to another suitor, Scottish tech firm Craneware avoids financing £ 80 million
“With each hospital that joins the platform, Trisus becomes more powerful,” Craneware said. “With the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four native Trisus cloud applications, we now have multiple ways for new and existing customers to join the Trisus community, giving them access to the platform’s other benefits.”
Shares in Craneware closed nearly 12 percent higher at 2,150p yesterday.